155 related articles for article (PubMed ID: 5367444)
1. Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa.
Herkert EE; Keup W
Psychopharmacologia; 1969; 15(1):48-59. PubMed ID: 5367444
[No Abstract] [Full Text] [Related]
2. Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states.
McNamee HB; Moody JP; Naylor GJ
J Psychosom Res; 1972 Feb; 16(1):63-70. PubMed ID: 5058989
[No Abstract] [Full Text] [Related]
3. Effects of L-DOPA treatment on indole metabolism in Parkinson's disease.
Brune GG; Pflughaupt KW
Experientia; 1971 May; 27(5):516. PubMed ID: 5132580
[No Abstract] [Full Text] [Related]
4. Urinary acid metabolites of biogenic amines in schizophrenic patients.
Domino EF
Schizophr Bull; 1980; 6(2):238-44. PubMed ID: 6154967
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
Huszka L; Zabek DH; Doust JW
Can Psychiatr Assoc J; 1976 Dec; 21(8):541-6. PubMed ID: 1071579
[No Abstract] [Full Text] [Related]
6. Analysis of urinary excretion patterns of bioactive amines and their metabolites in normal control subjects.
Hopkinson G; Baker GB; Douglass AB; McKim HR; Dewhurst WG
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):495-8. PubMed ID: 6187046
[No Abstract] [Full Text] [Related]
7. 5-Hydroxytryptamine and tryptamine pathways in scleroderma.
Stachow A; Jablonska S; Skiendzielewska A
Br J Dermatol; 1977 Aug; 97(2):147-54. PubMed ID: 911677
[TBL] [Abstract][Full Text] [Related]
8. Urinary studies of schizophrenics and controls.
Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
[No Abstract] [Full Text] [Related]
9. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
Spaide J; Neveln L; Tolentino J; Himwich HE
Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
[No Abstract] [Full Text] [Related]
10. Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma.
Stachów A; Jabłońska S; Skiendzielewska A
Acta Derm Venereol; 1979; 59(1):1-5. PubMed ID: 84460
[TBL] [Abstract][Full Text] [Related]
11. Amines and aphrodisiacs in chronic schizophrenia.
Lovett Doust JW; Huszka L
J Nerv Ment Dis; 1972 Oct; 155(4):261-4. PubMed ID: 5073357
[No Abstract] [Full Text] [Related]
12. High-performance liquid chromatographic determination of 5-hydroxyindole-3-acetic acid in urine using Sephadex G-10 for isolation.
Fornstedt N
J Chromatogr; 1980 Mar; 181(3-4):456-62. PubMed ID: 6156180
[No Abstract] [Full Text] [Related]
13. Effects of infused tryptamine in man.
Martin WR; Sloan JW
Psychopharmacologia; 1970; 18(3):231-7. PubMed ID: 4922520
[No Abstract] [Full Text] [Related]
14. [Tryptophan metabolism in patients with pellagra].
Brune GG; Brune RM; Wiskemann A
Arch Dermatol Forsch; 1970; 240(1):44-54. PubMed ID: 4252305
[No Abstract] [Full Text] [Related]
15. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
[No Abstract] [Full Text] [Related]
16. Indoleamines and affective disorders.
Coppen A
J Psychiatr Res; 1972 Sep; 9(3):163-71. PubMed ID: 5083172
[No Abstract] [Full Text] [Related]
17. Excretion of catecholamines and tryptophan derivatives in schizophrenia.
Mileikovskii YA
Neurosci Behav Physiol; 1979; 9(4):325-8. PubMed ID: 158714
[No Abstract] [Full Text] [Related]
18. [Tryptaminuria and urinary 5-H.I.A.A. in neuropsychiatry (preliminary note)].
Bourgeois M; Henry P
Ann Med Psychol (Paris); 1967 Oct; 125(3):Suppl 2:440-6. PubMed ID: 6081829
[No Abstract] [Full Text] [Related]
19. Urinary indoleamines in Tourette syndrome patients with obsessive-compulsive characteristics.
Bornstein RA; Baker GB
Psychiatry Res; 1992 Mar; 41(3):267-74. PubMed ID: 1375759
[TBL] [Abstract][Full Text] [Related]
20. Urinary 5-hydroxyindoleacetic acid in cases of hypertension before and after therapy with guanethidine and methyldopa.
Nath K; Agarwal SN; Mittal HS; Singh KN; Saxena S; Pant H
J Indian Med Assoc; 1972 Apr; 58(7):242-5. PubMed ID: 4537955
[No Abstract] [Full Text] [Related]
[Next] [New Search]
